Cassava Sciences Inc.

278 articles about Cassava Sciences Inc.

• Pain Therapeutics Announces Data Presentation At American Pain Society Meeting Supporting Development Of Oxytrex(TM)

  3/15/2006

• Pain Therapeutics To Present At The Citigroup Healthcare Conference

  2/22/2006

• Pain Therapeutics And King Pharmaceuticals®, Inc. Receive Special Protocol Assessment For Remoxy(TM) And Commence Pivotal Phase III

  2/16/2006

• Pain Therapeutics Announces Fourth Quarter And Year-End 2005 Financial Results

  1/17/2006

• Pain Therapeutics To Host Year-End Conference Call On January 17, 2006

  1/12/2006

• The Day In Review: Pain Therapeutics Gets $150 Million Payment From King Pharmaceuticals®, Inc.

  1/3/2006

• Pain Therapeutics Gets $150 Million In King Pharmaceuticals®, Inc. Deal

  1/3/2006

• Pain Therapeutics To Host Conference Call Today, Monday, December 12, 2005 9:00 A.M. Eastern Time

  12/12/2005

• Pain Therapeutics Terminates Drug Candidate For The Treatment Of Irritable Bowel Syndrome

  12/12/2005

• Pain Therapeutics Oxytrex Trial Fails To Cut Addiction In Statistically Meaningful Fashion

  11/22/2005

• DURECT Corporation Highlights Major Commercial Strategic Alliance For ORADUR(TM) Sustained Release Oral Gel-Cap Technology

  11/11/2005

• Pain Therapeutics And King Pharmaceuticals®, Inc. Team On Drug; Alliance Totaling About $400 Million

  11/10/2005

• Pain Therapeutics Announces Third Quarter 2005 Financial Results

  11/3/2005

• Pain Therapeutics To Present At The CIBC Healthcare Conference

  11/2/2005

• Pain Therapeutics Provides Oxytrex(TM) Update

  10/28/2005

• Pain Therapeutics, Inc. Late Stage Drugs For Mega-Markets

  9/19/2005

• Top 2003 Stories From The BioSpace NewsBeat

  12/31/2003

• Biotech Developing Abuse-Proof Oxycontin

  11/6/2003